Börsipäev 2. juuni

Investeerimine
21
Baird analüüsimaja on väljas positiivse reitingumuutusega Affymetrix (AFFX) kohta.
Baird tõstab AFFX reitingu Hoia pealt Osta peale ja hinnasihi $ 6 pealt $ 11 peale.

We are incrementally positive on AFFX's CEO management change. Dr. Frank Witney brings a string of successful leadership roles, many of which have ended as shareholder-favorable exits (takeovers). We expect Witney to hone in on AFFX's languishing revenue base while continuing the drive to improve gross and operating margins.

Analüütikud põhjendavad oma reitingumuutust sellega, et neile on väga meeltmööda vahetus ettevõtte juhtkonnas. Nad usuvad, et uus CEO dr. Witney toob firmasse hulganisti sektoripõhiseid kogemusi ja teadmisi.

Appoints new CEO. Dr. Witney brings strong industry knowledge, M&A experience, and familiarity with AFFX's products (he was with AFFX briefly post-Panomics acquisition). He most recently was the CEO of Dionex (DNEX), which just completed its $2.2 billion sale to TMO (Outperform-$63.86).Before that, Witney was CEO of Panomics, which was sold to AFFX in 2008. Before that, Witney was President and COO of Packard BioScience, which was sold to PerkinElmer (PKI-Outperform-$27.22) in 2001.

Uuel CEO-l on ka suur kogemus ülevõtmiste vallas, kuna enne oli ta juht Dionexis (DNEX), mis just viis lõpule oma $ 2,2 miljardi suuruse müügi TMO-le. Lisaks eelnevale on ta tuttav ka AFFX toodetega.

Top-line growth a likely focus. AFFX has seen organic revenue declines for 12 of the past 14 quarters. Chip volumes have been increasing over the past couple of quarters, offset by unfavorable mix of lower-cost/content chips and we think this could continue in Q2-11. That said, we think Witney will make a return to growth a top priority. One area of focus could be Witney's former Panomics business and new cytogenetics products scheduled for Q3-11 release.

Fookuses saab kindlasti olema firma finantstulemuste parandamine, kuna ettevõtte käive on viimase 14 kvartali jooksul 12 kvartalit langenud. Analüütikud usuvad, et Witney suudab ettevõtte uuesti kasvutrendi tagasi tuua.

Baird ei ole just väga mõjukas analüüsimaja, aga silma jäi call seetõttu, et analüütikute uus hinnasiht on street high ning konsensusel on ettevõtte suhtes pigem madalad ootused ja suure kogemusepagasiga CEO võib firmasse uusi tuuli tuua. Antud call tahab turu toestust ka.

22
NC on täna esile tõstnud Janney poolt Chipotle Mexican Grill-ile (CMG) poitiivsed kommentaarid ja pealkirjaks A $1,000+ Stock? - Janney
Peaks investorite seas huvi pakkuma, selliseid kommentaare ei näe iga päev.
Link:http://notablecalls.blogspot.com/
23
AFFX töötas täna kenasti, aga paraku ei pakkunud aktsia eriti soodsat hinnataset. Aktsa avanes $ 6,55 pealt ehk üle 4% ülevalt ning liikus peale avanemist sirgjoones üles, käies ära ka $ 7,05 peal. Hetkel kaupleb aktsia $ 6,92 kandis ehk 10,2% plusspoolel.

24
Senior euro zone officials have agreed in principle on a new 3-yr adjustment program for Greece to run until mid-2014 and involve increased external funding, according to report
25
Treasuries, dollar hitting lows as headlines cross regarding Moody's comments suggesting it could place U.S. Govt rating on review for downgrade if progress isn't made on increasing debt limit
26
Moodys updates rating implications of US budget negotiations; if no progress on increasing debt limit in coming weeks, expects to place US government's rating under review for possible downgrade
Moodyselt ikka väga julge kommentaar.
27
The market is pulling back from highs and the dollar is spiking vs. the euro; coincides with headlines suggesting a lack of agreement on new Greek aid plan
28
Groupon files for IPO in S-1; files for $750 mln class A common stock